President & Managing Partner
François Thomas has more than 25 years of experience in the life sciences sector. Before becoming Manager Partner Inserm Transfert Initiative
in 2014, he held management positions at Ipsen (VP Clinical Development and CMO) and Genset (VP Licensing and Pharmacogenomics).
In 2002, François became Partner at Atlas Venture and in 2006 he was responsible for healthcare corporate finance at the bank Bryan Garnier. Most recently, he was CEO of Cytheris, a private biotech company.
François has been a board member of several biotech companies such as Eurogentec YMB and Gamamabs, as well as representative of Atlas and ITI in over 20 boards. In addition, in 1995 François founded a consultancy company called Bioserve Ltd.
François is medical oncologist, a former assistant professor at the Gustave Roussy Institute, and holds a Ph. D in molecular oncology and an MBA from MIT (Boston).
Jean-Briac Lesne started his professional career in the Life Sciences Venture Capital team of Omnes Capital.
Afterwards, he worked for Hyperion CD, an M&A and licensing advisory company dedicated to life sciences industries. In early 2015, he joined the management team of Inserm Transfert Initiative as analyst.
Jean-Briac holds a Pharm.D. from Rennes University and graduated from ESCP-Europe Business School.